EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modified gegen qinlian decoction ameliorates Veillonella parvula-exacerbated ulcerative colitis via restoration of intestinal mucosal barrier function

Meiling She, Xinyi Dai, Xintong Wang, Zheng Wang, Jiaqi Zhang, Zhuo Shi, Ying Peng, Xiaobo Li, Ting Chen, Xudong Tang

Frontiers in Pharmacology · 21.04.2026 · 17

DOI: 10.3389/fphar.2026.1803816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 21.04.2026. Verfasst von Meiling She und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Natural Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ulcerative colitis (UC) is being increasingly connected to the pathogen Veillonella parvula (V. parvula). Modified Gegen Qinlian Decoction (MGQD), a traditional Chinese medicine therapy, is used to treat UC. However, the underlying mechanism by which V. parvula exacerbates UC and whether MGQD can alleviate it is unknown.

Methods

MGQD therapy was tested on pathogen-free and pseudo-germ-free mice infected with V. parvula. Colitis severity was determined by disease activity index, colon length, and histology. Transmission electron microscopy, Western blot, immunofluorescence, and immunohistochemistry were used to assess the integrity of the intestinal mucosal barrier. In vitro , mouse colonic organoids were utilized to examine the effects of baicalin and puerarin on inflammation-induced downregulation of Muc2 and ZO-1.

Results

MGQD therapy dramatically reduced the severity of colitis in both mouse models. MGQD restored the integrity of the mucus and mechanical barriers. Furthermore, baicalin and puerarin reduced inflammation-induced downregulation of Muc2 and ZO-1 in mouse colonic organoids.

Discussion

These findings demonstrate that MGQD alleviates intestinal barrier dysfunction caused by V. parvula, providing novel mechanistic insight for the management of chronic colitis.

Schlagwörter

Stichwörter der Autor:innen

Veillonella parvulaintestinal barriersmechanical barriermucus barrierulcerative colitis

Autor:innen und Institutionen

  • Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • China Academy of Chinese Medical Sciences, Beijing, China.
  • School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.

Förderung

  • National Institutes of Natural Sciences

Zitieren

APA

She, M., Dai, X., Wang, X., Wang, Z., Zhang, J., Shi, Z., Peng, Y., Li, X., Chen, T., & Tang, X. (2026). Modified gegen qinlian decoction ameliorates Veillonella parvula-exacerbated ulcerative colitis via restoration of intestinal mucosal barrier function. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1803816

Vancouver

She M, Dai X, Wang X, Wang Z, Zhang J, Shi Z, et al. Modified gegen qinlian decoction ameliorates Veillonella parvula-exacerbated ulcerative colitis via restoration of intestinal mucosal barrier function. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1803816

BibTeX
@article{She2026,
  author = {She, Meiling and Dai, Xinyi and Wang, Xintong and Wang, Zheng and Zhang, Jiaqi and Shi, Zhuo and Peng, Ying and Li, Xiaobo and Chen, Ting and Tang, Xudong},
  title = {Modified gegen qinlian decoction ameliorates Veillonella parvula-exacerbated ulcerative colitis via restoration of intestinal mucosal barrier function},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1803816}
}
Kostenlos starten →